Skip to main content
DIMERIX LIMITED logo

DIMERIX LIMITED — Investor Relations & Filings

Ticker · DXB ISIN · AU000000DXB7 ASX Professional, scientific and technical activities
Open in API
Filings indexed 1,124 across all filing types
Latest filing 2008-02-13 Board/Management Inform…
Country AU Australia
Listing ASX DXB

About DIMERIX LIMITED

https://dimerix.com/

Dimerix Limited focuses on the development of therapeutic treatments for inflammatory diseases, with a primary emphasis on kidney and respiratory conditions. The company utilizes its proprietary Receptor-Heteromer Investigation Technology (DMX-Technology) to identify and validate G protein-coupled receptor (GPCR) targets. Its lead candidate, DMX-200, is a chemokine receptor (CCR2) antagonist currently in Phase 3 clinical trials for the treatment of Focal Segmental Glomerulosclerosis (FSGS). The company is also advancing DMX-700 for Chronic Obstructive Pulmonary Disease (COPD) and exploring applications for diabetic kidney disease. The core strategy involves targeting multiple signaling pathways simultaneously to address unmet medical needs in chronic inflammatory and fibrotic diseases.

Recent filings

Filing Released Lang Actions
Management Change 1 page ?Kb
Board/Management Information Classification · 100% confidence The document is an ASX Company Announcement dated 14 February 2008 regarding a management change: the resignation of the Chief Financial Officer as an executive and his continuation as a non-executive board member. There is no financial data, report, or presentation included. The content clearly relates to changes in senior management. Therefore, the document fits the category of Board/Management Information (MANG). The document length is short and focused solely on management change, confirming this classification.
2008-02-13 English
New Distribution Agreements 2 pages ?Kb
Regulatory Filings Classification · 95% confidence The document is an ASX Company Announcement dated 13 February 2008. It details new distribution agreements signed by the company's subsidiary, including terms, estimated sales, and regulatory expectations. There is no indication that this is a financial report, earnings release, or management discussion. The content is a corporate announcement about business agreements, not a report or presentation. The document length is 4066 characters, which is relatively short and typical for an announcement. Therefore, the document fits best into the category of a Regulatory Filing (RNS), which is a general category for regulatory announcements that do not fit other specific categories.
2008-02-12 English
Completion of Share Purchase Plan 1 page ?Kb
Capital/Financing Update Classification · 95% confidence The document is an ASX company announcement dated 1 February 2008 regarding the completion of a Share Purchase Plan (SPP). It details the number of shares applied for, the amount raised, and the intended use of funds. This is an update on a capital raising activity, not a full financial report or earnings release. The document is short and focused on financing activity, specifically the completion of a share purchase plan. Therefore, it fits the category of Capital/Financing Update (CAP).
2008-01-31 English
Appendix 3B 8 pages ?Kb
Capital/Financing Update Classification · 95% confidence The document is titled 'Appendix 3B' and is an announcement related to a new issue of securities, application for quotation of additional securities, and agreement with the ASX (Australian Securities Exchange). It details the class and number of securities issued, issue price, purpose of the issue, and other related information about the securities. The document is regulatory in nature, focused on capital raising and securities issuance, not a financial report or earnings release. It fits the description of a Capital/Financing Update, which covers company fundraising and capital structure changes. The document length is over 10,000 characters and contains detailed information about the securities issued, confirming it is not a mere announcement of a report but a substantive filing about capital changes.
2008-01-31 English
Change of Director`s Interest Notice 2 pages ?Kb
Director's Dealing Classification · 100% confidence The document is titled 'Appendix 3Y Change of Director’s Interest Notice' and details changes in securities holdings by a company director, including number of shares held before and after the change, nature of the transaction (share purchase plan), and dates. It references ASX listing rules and Corporations Act sections related to director interests. This matches the definition of a Director's Dealing report, which reports personal share transactions by company directors and executives (insider trades). The document length is short and focused solely on director share transactions, with no financial results or other report content.
2008-01-31 English
Correction to Appendix 3B 9 pages ?Kb
Share Issue/Capital Change Classification · 100% confidence The document is an ASX Company Announcement dated 1 February 2008, titled 'CORRECTION TO APPENDIX 3B'. It corrects the number of shares allotted under a share purchase plan and includes an amended Appendix 3B form. Appendix 3B is a standard form used for new issue announcements, application for quotation of additional securities, and agreements related to securities issuance on the Australian Securities Exchange (ASX). The document details the class and number of securities issued, issue price, purpose of the issue, and other related information. It is not a full financial report, earnings release, or management discussion but rather a formal announcement regarding a capital change (share issuance and quotation). The presence of the Appendix 3B form and the nature of the content clearly indicate this is a Share Issue/Capital Change announcement. The document length and detail confirm it is not merely a brief notice or report publication announcement but a substantive filing about capital changes.
2008-01-31 English

Browse filings by year

24 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.